Raffaella Iantomasi

Title: Raffaella Iantomasí: An Innovator in Meningococcal Vaccine Development

Introduction

Raffaella Iantomasí, located in Paris, France, is an accomplished inventor known for her significant contributions to vaccine development. As a dedicated researcher at Sanofi Pasteur Inc., she has played a vital role in advancing immunological science, particularly in combating meningococcal diseases.

Latest Patents

Raffaella holds a patent for a Meningococcal B recombinant vaccine. This innovative immunogenic composition features a combination of meningococcal antigens, including at least one factor H binding protein (fHBP) A, one fHBP B protein, one adhesin A (NadA) protein, and one detergent-extracted Outer Membrane Vesicle (dOMV). The formulation is designed to provide broad coverage against various bacterial strains of serogroup B. Furthermore, the patent also outlines methods for utilizing this immunogenic composition to effectively elicit an immune response.

Career Highlights

Throughout her career, Raffaella has demonstrated a strong commitment to enhancing public health through her work in vaccine research and development. Her pioneering efforts in creating effective vaccines underline her status as a leader in the scientific community. With one patent to her name, she exemplifies the innovative spirit that drives advancements in medicine.

Collaborations

Raffaella collaborates with esteemed colleagues such as Nadège Arnaud-Barbe and Vinod Balhara, further enhancing her research efforts and contributing to a collaborative environment conducive to groundbreaking discoveries. These partnerships reflect the importance of teamwork in the pursuit of scientific progress.

Conclusion

Raffaella Iantomasí stands out as a key figure in the field of vaccine development. Her patent for the Meningococcal B recombinant vaccine showcases her innovative approach to addressing public health challenges. As she continues her impactful work at Sanofi Pasteur Inc., the scientific community and patients alike can look forward to the benefits of her research in immunology.